|
Biora Therapeutics Inc (NASDAQ: BIOR) |
|
Biora Therapeutics Inc
BIOR's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Looking into Biora Therapeutics Inc growth rates, revenue grew
in III. Quarter 2024 from the same quarter a year ago.
Ranking at No. 2924
Major Pharmaceutical Preparations industry recorded
deterioration of revenues by -4.85 %
Biora Therapeutics Inc net loss decreased from $-73 millions, to $-18 millions in III. Quarter 2024,
• More on BIOR's Growth
|
|
Biora Therapeutics Inc realized a net loss in trailing twelve months.
Biora Therapeutics Inc realized cash reduction of $ -25.66 per share in trailing twelve-month period. |
Company |
-0 |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.09.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.1.
• More on BIOR's Valuation
|
|
|
|
|
Biora Therapeutics Inc realized net loss in trailing twelve months.
Biora Therapeutics Inc realized cash outflow of $ -25.66per share in trailing twelve-month period. |
Company |
-0 |
PE TTM
|
Industry |
- |
PE TTM
|
|
Company's Price to Sales ratio is at 0.09.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.1.
• More on BIOR's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com